Overview

Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether low-molecular-weight heparin could be equally or more effective than oral anticoagulation in the long-term treatment of deep venous thrombosis.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital Universitari de Bellvitge
Collaborator:
LEO Pharma
Treatments:
Acenocoumarol
Anticoagulants
Calcium heparin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin
Vitamin K
Vitamins